Study touches off cholesterol debate
Merck and Schering-Plough are running full page ads, as in the Wall Street Journal, in an attempt to control the damage from a study questioning the benefits of ezetimibe (Zetia) or Vytorin (ezetimibe/simvastatin). “All of […]



